Commentary: The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study.
作者信息
Grzybowska Magdalena Emilia
机构信息
Department of Gynecology, Gynecological Oncology and Gynecological Endocrinology, Medical University of Gdansk, Gdańsk, Poland.
出版信息
Front Cell Infect Microbiol. 2020 Feb 25;10:64. doi: 10.3389/fcimb.2020.00064. eCollection 2020.
Abstract
摘要
相似文献
1
Commentary: The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study.评论：与未受影响的对照组相比，绝经前患有间质性膀胱炎/膀胱疼痛综合征的女性的阴道和泌尿微生物群：一项试点横断面研究。
Front Cell Infect Microbiol. 2020 Feb 25;10:64. doi: 10.3389/fcimb.2020.00064. eCollection 2020.
2
The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study.绝经前女性间质性膀胱炎/膀胱疼痛综合征与无影响对照者的阴道和尿路微生物组：一项初步的横断面研究。
Front Cell Infect Microbiol. 2019 Apr 8;9:92. doi: 10.3389/fcimb.2019.00092. eCollection 2019.
3
Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.间质性膀胱炎女性的尿液微生物群和细胞因子水平
Obstet Gynecol. 2017 Mar;129(3):500-506. doi: 10.1097/AOG.0000000000001892.
4
Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.膀胱内注射透明质酸溶液治疗难治性间质性膀胱炎/膀胱疼痛综合征后女性性功能的变化。
J Sex Med. 2014 Sep;11(9):2256-63. doi: 10.1111/jsm.12507. Epub 2014 Mar 17.
5
Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS).局部雌激素疗法（LET）对绝经前间质性膀胱炎/膀胱疼痛综合征（IC/BPS）女性泌尿及性症状的影响。
Gynecol Endocrinol. 2015 Oct;31(10):828-32. doi: 10.3109/09513590.2015.1063119. Epub 2015 Jul 31.
6
Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?非复杂性膀胱炎和间质性膀胱炎患者的尿微生物组：有何相似之处？
World J Urol. 2020 Nov;38(11):2721-2731. doi: 10.1007/s00345-020-03099-x. Epub 2020 Jan 31.
7
Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.透明质酸治疗后间质性膀胱炎/膀胱疼痛综合征女性的泌尿及心理结局
Taiwan J Obstet Gynecol. 2018 Jun;57(3):360-363. doi: 10.1016/j.tjog.2018.04.006.
8
Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.与间质性膀胱炎/膀胱疼痛综合征的膀胱容量相关的基因表达。
J Urol. 2014 Oct;192(4):1123-9. doi: 10.1016/j.juro.2014.05.047. Epub 2014 May 17.
9
Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.有或无性虐待史的间质性膀胱炎/膀胱疼痛综合征患者临床表现的差异。
J Urol. 2008 Nov;180(5):2029-33. doi: 10.1016/j.juro.2008.07.053. Epub 2008 Sep 18.
10
Non-bladder conditions in female Taiwanese patients with interstitial cystitis/hypersensitive bladder syndrome.台湾女性间质性膀胱炎/膀胱过敏综合征患者的非膀胱疾病情况
Int J Urol. 2014 Aug;21(8):805-9. doi: 10.1111/iju.12456. Epub 2014 Apr 13.
本文引用的文献
1
2
Improving clinical outcomes with lower motor voltage (≤3 V) during stage 1 sacral neuromodulation for interstitial cystitis or bladder pain syndrome.通过在第一阶段骶神经调节时使用较低的运动电压（≤3V）来改善间质性膀胱炎或膀胱疼痛综合征的临床结果。
Neurourol Urodyn. 2019 Nov;38(8):2233-2241. doi: 10.1002/nau.24123. Epub 2019 Sep 12.
3
The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut-brain axis.肠道微生物组与药理学：靶向治疗肠道-脑轴的药物处方。
Curr Opin Pharmacol. 2019 Dec;49:17-23. doi: 10.1016/j.coph.2019.04.007. Epub 2019 May 10.
4
The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study.绝经前女性间质性膀胱炎/膀胱疼痛综合征与无影响对照者的阴道和尿路微生物组：一项初步的横断面研究。
Front Cell Infect Microbiol. 2019 Apr 8;9:92. doi: 10.3389/fcimb.2019.00092. eCollection 2019.
5
Sexual Dysfunction in Interstitial Cystitis.间质性膀胱炎中的性功能障碍
Curr Urol. 2017 Nov;11(1):1-3. doi: 10.1159/000447186. Epub 2017 Nov 30.
6
Validation of a single summary score for the Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).国际尿控协会修订的盆腔器官脱垂/尿失禁性功能问卷（PISQ-IR）单一汇总评分的验证
Int Urogynecol J. 2017 Dec;28(12):1901-1907. doi: 10.1007/s00192-017-3373-9. Epub 2017 Jun 6.
7
Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.间质性膀胱炎女性的尿液微生物群和细胞因子水平
Obstet Gynecol. 2017 Mar;129(3):500-506. doi: 10.1097/AOG.0000000000001892.
8
German translation and validation of the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-IUGA revised (PISQ-IR).盆底器官脱垂/尿失禁性功能问卷-IUGA修订版（PISQ-IR）的德文翻译与验证。
Int Urogynecol J. 2016 Aug;27(8):1235-44. doi: 10.1007/s00192-016-2969-9. Epub 2016 Feb 16.
9
A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care.间质性膀胱炎/膀胱疼痛综合征评估与管理的多学科方法：一种理想的照护模式。
Transl Androl Urol. 2015 Dec;4(6):611-9. doi: 10.3978/j.issn.2223-4683.2015.10.10.
10
Incontinence medication response relates to the female urinary microbiota.尿失禁药物反应与女性泌尿微生物群有关。
Int Urogynecol J. 2016 May;27(5):723-33. doi: 10.1007/s00192-015-2847-x. Epub 2015 Sep 30.
Zotero 插件